Isolation of group B Streptococcus with reduced β-lactam susceptibility from pregnant women
β-Lactam antibiotics are first-line agents for the treatment and prevention of group B Streptococcus (GBS) infections. We previously reported clinical GBS isolates with reduced β-lactam susceptibility (GBS-RBS) and characterized them as harbouring amino acid substitutions in penicillin-binding prote...
Saved in:
| Main Authors: | Hiroaki Moroi, Kouji Kimura, Tomomi Kotani, Hiroyuki Tsuda, Hirotsugu Banno, Wanchun Jin, Jun-ichi Wachino, Keiko Yamada, Takashi Mitsui, Mamoru Yamashita, Fumitaka Kikkawa, Yoshichika Arakawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-01-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2018.1557987 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Invasive Group B Streptococcus Infections Caused by Hypervirulent Clone of S. agalactiae Sequence Type 283, Hong Kong, China, 2021
by: Carmen Li, et al.
Published: (2025-01-01) -
Detection of Group B Streptococcus (GBS) from Antenatal Screening, Maternal GBS Colonization and Incidence of Early-Onset Neonatal Disease (GBS-EOD): A National Survey, December 2022 to February 2023, Italy
by: Michela Sabbatucci, et al.
Published: (2025-06-01) -
Serum-equivalency comparison, detection, and quantification of Group B Streptococcus anti-capsular polysaccharide antibodies from dried blood spots
by: Shanna Bolcen, et al.
Published: (2025-12-01) -
Antibiotic Resistance and Serotypes Distribution in Streptococcus agalactiae Bulgarian Clinical Isolates During the Years of 2021–2024
by: Boyanov Vasil S., et al.
Published: (2024-12-01) -
Genetic Mechanisms of Antimicrobial Non-Susceptibility to Novel Fluoroquinolone Delafloxacin Among Bulgarian Clinical Isolates of <i>Streptococcus agalactiae</i>
by: Vasil Boyanov, et al.
Published: (2025-06-01)